{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:14:32Z","timestamp":1773292472445,"version":"3.50.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T00:00:00Z","timestamp":1299628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0016804","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T22:05:19Z","timestamp":1299708319000},"page":"e16804","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders"],"prefix":"10.1371","volume":"6","author":[{"given":"Ajay","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u2032Alim J.","family":"Beveridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neena","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,3,9]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions.","volume":"95","author":"SB Prusiner","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrmicro1492","article-title":"Pathogenesis of prion diseases: current status and future outlook.","volume":"4","author":"A Aguzzi","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.56.7.986","article-title":"Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.","volume":"56","author":"AJ Green","year":"2001","journal-title":"Neurol"},{"issue":"7","key":"ref4","first-page":"19","article-title":"CSF Assay: Debate Over CJD Tests Remains Gridlocked.","volume":"2","author":"S Kurt","year":"2002","journal-title":"Neurology Today"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.60.6.813","article-title":"Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.","volume":"60","author":"MD Geschwind","year":"2003","journal-title":"Arch Neurol"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archneur.60.6.803","article-title":"Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation.","volume":"60","author":"AJ Aksamit","year":"2003","journal-title":"Arch Neurol"},{"issue":"3-4","key":"ref7","first-page":"191","article-title":"Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease.","volume":"21","author":"M Otto","year":"2003","journal-title":"Restor Neurol Neurosci"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.clineuro.2004.12.002","article-title":"Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.","volume":"107","author":"B Van Everbroeck","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"16378","DOI":"10.1073\/pnas.172403799","article-title":"Transmission of prions.","volume":"99","author":"C Weissmann","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymeth.2007.06.012","article-title":"Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.","volume":"44","author":"M Otto","year":"2008","journal-title":"Methods"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ana.21430","article-title":"Rapidly progressive dementia.","volume":"64","author":"MD Geschwind","year":"2008","journal-title":"Ann Neurol"},{"issue":"13","key":"ref12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","article-title":"The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.","volume":"335","author":"G Hsich","year":"1996","journal-title":"N Engl J Med"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","article-title":"Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt\u2013Jakob disease.","volume":"58","author":"M Otto","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","article-title":"CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.","volume":"67","author":"P Sanchez-Juan","year":"2006","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awm063","article-title":"Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance.","volume":"130","author":"U Heinemann","year":"2007","journal-title":"Brain"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-2009-1075","article-title":"Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer&apos;s disease and Creutzfeldt-Jakob disease.","volume":"17","author":"S Jesse","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2009.02.067","article-title":"The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.","volume":"455","author":"C Pennington","year":"2009","journal-title":"Neurosci Lett"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.WNL.0000135153.96325.3B","article-title":"Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease.","volume":"63","author":"RJ Castellani","year":"2004","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2377-6-25","article-title":"Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.","volume":"6","author":"N Cuadrado-Corrales","year":"2006","journal-title":"BMC Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","article-title":"Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.","volume":"129","author":"SJ Collins","year":"2006","journal-title":"Brain"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00415-006-0472-9","article-title":"Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.","volume":"254","author":"P Sanchez-Juan","year":"2007","journal-title":"J Neurol"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.neurobiolaging.2008.01.007","article-title":"14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes.","volume":"30","author":"K Gmitterov\u00e1","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","article-title":"Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.","volume":"43","author":"I Zerr","year":"1998","journal-title":"Ann Neurol"},{"key":"ref24","first-page":"1","article-title":"Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report from a WHO consultation.","volume":"1998"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/15622970510029786","article-title":"Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.","volume":"6","author":"J Wiltfang","year":"2005","journal-title":"World J Biol Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1743-8454-5-14","article-title":"Cerebrospinal fluid markers in Creutzfeldt-Jakob disease.","volume":"5","author":"A Skinningsrud","year":"2008","journal-title":"Cerebrospinal Fluid Res"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000107082","article-title":"Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.","volume":"24","author":"K Satoh","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1007\/s00415-009-5160-0","article-title":"Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.","volume":"256","author":"IE Baldeiras","year":"2009","journal-title":"J Neurol"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/01.WNL.0000063313.57292.00","article-title":"Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.","volume":"60","author":"G Franz","year":"2003","journal-title":"Neurology"},{"issue":"16","key":"ref30","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased beta-amyloid 1\u201342 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.","volume":"289","author":"T Sunderland","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(01)01556-7","article-title":"Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases.","volume":"300","author":"SD S\u00fcssmuth","year":"2001","journal-title":"Neurosci Lett"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"e1000336","DOI":"10.1371\/journal.ppat.1000336","article-title":"Abnormal brain iron homeostasis in human and animal prion disorders.","volume":"5","author":"A Singh","year":"2009","journal-title":"PLoS Pathogens"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/msb.2009.10","article-title":"A systems approach to prion disease.","volume":"5","author":"D Hwang","year":"2009","journal-title":"Mol Syst Biol"},{"key":"ref34","first-page":"6","article-title":"A systems biologist ponders how disparate ideas can sometimes come together beautifully.","volume":"460","author":"D Kell","year":"2009","journal-title":"Nature"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2007.05.061","article-title":"Alteration of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapie-infected mice.","volume":"422","author":"BH Kim","year":"2007","journal-title":"Neurosci Lett"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00204-010-0577-x","article-title":"Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson&apos;s. Huntington&apos;s, Alzheimer&apos;s, prions, bactericides, chemical toxicology and others as examples.","volume":"84","author":"DB Kell","year":"2010","journal-title":"Arch Toxicol"},{"key":"ref37","article-title":"Using Multivariate Statistics (4th ed.).","author":"BG Tabachnick","year":"2000"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","article-title":"Consensus report of the Working Group on: &quot;Molecular and Biochemical Markers of Alzheimer&apos;s Disease&quot;.","volume":"19","year":"1998","journal-title":"Neurobiol Aging"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF Biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.","volume":"302","author":"N Mattsson","year":"2009","journal-title":"JAMA"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-Sided Confidence Intervals for the Single Proportion: Comparison of Seven Methods.","volume":"17","author":"RG Newcombe","year":"1998","journal-title":"Stat Med"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0895-4356(91)90128-V","article-title":"Likelihood ratios with confidence: sample size estimation for diagnostic test studies.","volume":"44","author":"DL Simel","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"ref42","doi-asserted-by":"crossref","DOI":"10.1201\/9780429258589","article-title":"Practical Statistics for Medical Research.","author":"DG Altman","year":"1990"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.71.3.401","article-title":"Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer&apos;s disease?","volume":"71","author":"E Kapaki","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","article-title":"Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease.","volume":"225","author":"M Otto","year":"1997","journal-title":"Neurosci Lett"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.74.9.1210","article-title":"A prospective study of CSF markers in 250 patients with possible Creutzfeldt\u2013Jakob disease.","volume":"74","author":"B Van-Everbroeck","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00415-004-0311-9","article-title":"Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.","volume":"251","author":"B Van Everbroeck","year":"2004","journal-title":"J Neurol"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2869.2004.00403.x","article-title":"CSF iron, ferritin and transferrin levels in restless legs syndrome.","volume":"14","author":"S Mizuno","year":"2005","journal-title":"J Sleep Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11910-008-0026-x","article-title":"Pathophysiology of restless legs syndrome: evidence for iron involvement.","volume":"8","author":"JR Connor","year":"2008","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.lab.2005.06.011","article-title":"Ferritin subunits in CSF are decreased in restless legs syndrome.","volume":"147","author":"L Clardy S","year":"2006","journal-title":"J Lab Clin Med"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006948027674","article-title":"Transferrin and transferrin receptor function in brain barrier systems.","volume":"20","author":"T Moos","year":"2000","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/ars.2007.1893","article-title":"Intracellular Iron Transport and Storage: From Molecular Mechanisms to Health Implications.","volume":"10","author":"EL MacKenzie","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1073\/pnas.86.18.7260","article-title":"Changes in brain gene expression shared by scrapie and Alzheimer disease.","volume":"86","author":"JR Duguid","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1002\/pmic.200500294","article-title":"Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping.","volume":"6","author":"C Piubelli","year":"2006","journal-title":"Proteomics"},{"issue":"20","key":"ref54","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1002\/pmic.200800375","article-title":"Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt\u2013Jakob disease.","volume":"8","author":"P Brechlin","year":"2008","journal-title":"Proteomics"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1373\/clinchem.2005.054916","article-title":"Separation of \u03b2<sub>2<\/sub>-Transferrin by Denaturing Gel Electrophoresis to Detect Cerebrospinal Fluid in Ear and Nasal Fluids.","volume":"51","author":"T G\u00f6r\u00f6gh","year":"2005","journal-title":"Clinical Chemistry"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0016804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T17:40:18Z","timestamp":1685986818000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0016804"}},"subtitle":[],"editor":[{"given":"Jiyan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,9]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0016804","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,9]]}}}